Literature DB >> 19458878

What do predict anxiety and depression in breast cancer patients? A follow-up study.

Mariam Vahdaninia1, Sepideh Omidvari, Ali Montazeri.   

Abstract

INTRODUCTION: Psychological adjustment following cancer occurrence remains a key issue among the survivors. This study aimed to investigate psychological distress in patients with breast cancer following completion of breast cancer treatments and to determine its associated factors.
MATERIALS AND METHODS: This was a prospective study of anxiety and depression in breast cancer patients. Anxiety and depression were measured using the Hospital Anxiety and Depression Scale at three points in time: baseline (pre-diagnosis), 3 months after initial treatment and 1 year after completion of treatment (in all 18 months follow-up). At baseline, the questionnaires were administered to all the suspected patients while both patients and the interviewer were blind to the final diagnosis. Socio-demographic and clinical data included age, education, marital status, disease stage and initial treatment. Repeated measure analysis was performed to compare anxiety and depression over the study period. Logistic regression analysis was performed to determine variables that predict anxiety and depression.
RESULTS: Altogether 167 patients were diagnosed with breast cancer. The mean age of breast cancer patients was 47.2 (SD = 13.5) years, and the vast majority underwent mastectomy (82.6%). At 18 months follow-up, data for 99 patients were available. The results showed that anxiety and depression improved over the time (P < 0.001) although at 18-month follow-up, 38.4% and 22.2% of the patients presented with severe anxiety and depression, respectively. 'Fatigue' was found to be a risk factor for developing anxiety and depression at 3 months follow-up [odds ratio (OR) = 1.04, 95% Confidence interval (CI) = 1.01-1.07 and OR = 1.04, 95% CI = 1.02-1.07 respectively]. At 18 months follow-up, anxiety was predicted by 'pain' (OR = 1.02, 95% CI = 1.00-1.05), whereas depression was predicted by both 'fatigue' (OR = 1.06, 95% CI = 1.02-1.09) and 'pain' (OR = 1.05, 95% CI = 1.01-1.08).
CONCLUSION: Although the findings indicated that the levels of anxiety and depression decreased over time, a significant number of women had elevated anxiety and depression at the 18 months follow-up. This suggests that all women should be routinely screened for psychological distress and that quality cancer care include processes to treat that 30% of women who have elevated psychological distress. In addition, if breast cancer patients indicated that they are suffering from fatigue or pain, these women who are at particular risk should be especially screened.

Entities:  

Mesh:

Year:  2009        PMID: 19458878     DOI: 10.1007/s00127-009-0068-7

Source DB:  PubMed          Journal:  Soc Psychiatry Psychiatr Epidemiol        ISSN: 0933-7954            Impact factor:   4.328


  37 in total

1.  Breast cancer in Iran: a review of 903 case records.

Authors:  I Harirchi; M Ebrahimi; N Zamani; S Jarvandi; A Montazeri
Journal:  Public Health       Date:  2000-03       Impact factor: 2.427

2.  Psychological distress following first recurrence of disease in patients with breast cancer: prevalence and risk factors.

Authors:  H Okamura; T Watanabe; M Narabayashi; N Katsumata; M Ando; I Adachi; T Akechi; Y Uchitomi
Journal:  Breast Cancer Res Treat       Date:  2000-05       Impact factor: 4.872

3.  Differences in patterns of depression after treatment for breast cancer.

Authors:  Teresa Deshields; Tiffany Tibbs; Ming-Yu Fan; Marie Taylor
Journal:  Psychooncology       Date:  2006-05       Impact factor: 3.894

Review 4.  Psychological and social aspects of breast cancer.

Authors:  Patricia A Ganz
Journal:  Oncology (Williston Park)       Date:  2008-05       Impact factor: 2.990

5.  Fatigue and depression in disease-free breast cancer survivors: prevalence, correlates, and association with quality of life.

Authors:  Soo Hyun Kim; Byung Ho Son; Sook Yeon Hwang; Wonshik Han; Jung-Hyun Yang; Seeyoun Lee; Young Ho Yun
Journal:  J Pain Symptom Manage       Date:  2008-03-20       Impact factor: 3.612

6.  Psychiatric disorder in women with early stage and advanced breast cancer: a comparative analysis.

Authors:  David W Kissane; Brenda Grabsch; Anthony Love; David M Clarke; Sidney Bloch; Graeme C Smith
Journal:  Aust N Z J Psychiatry       Date:  2004-05       Impact factor: 5.744

7.  Fatigue in breast cancer survivors two to five years post diagnosis: a HEAL Study report.

Authors:  Kathleen Meeske; Ashley Wilder Smith; Catherine M Alfano; Bonnie A McGregor; Anne McTiernan; Kathy B Baumgartner; Kathleen E Malone; Bryce B Reeve; Rachel Ballard-Barbash; Leslie Bernstein
Journal:  Qual Life Res       Date:  2007-04-25       Impact factor: 4.147

Review 8.  Breast cancer in Iran: an epidemiological review.

Authors:  Seyed Mohsen Mousavi; Ali Montazeri; Mohammad Ali Mohagheghi; Alireza Mousavi Jarrahi; Iraj Harirchi; Masomeh Najafi; Mandana Ebrahimi
Journal:  Breast J       Date:  2007 Jul-Aug       Impact factor: 2.431

9.  Assessing the independent contribution to quality of life from anxiety and depression in patients with advanced cancer.

Authors:  E M Smith; S A Gomm; C M Dickens
Journal:  Palliat Med       Date:  2003-09       Impact factor: 4.762

View more
  64 in total

1.  Depressive symptoms and health-related quality of life in breast cancer survivors.

Authors:  Cielito C Reyes-Gibby; Karen O Anderson; Phuong Kanh Morrow; Sanjay Shete; Sohela Hassan
Journal:  J Womens Health (Larchmt)       Date:  2011-11-07       Impact factor: 2.681

2.  Cancer Type and Risk of Newly Diagnosed Depression Among Elderly Medicare Beneficiaries With Incident Breast, Colorectal, and Prostate Cancers.

Authors:  Monira Alwhaibi; Usha Sambamoorthi; Suresh Madhavan; Thomas Bias; Kimberly Kelly; James Walkup
Journal:  J Natl Compr Canc Netw       Date:  2017-01       Impact factor: 11.908

3.  Serious psychological distress among non-Hispanic whites in the United States: the importance of nativity status and region of birth.

Authors:  Florence J Dallo; Tiffany B Kindratt; Tracy Snell
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2013-05-10       Impact factor: 4.328

4.  Predictors of initial levels and trajectories of anxiety in women before and for 6 months after breast cancer surgery.

Authors:  Marianna Kyranou; Kathleen Puntillo; Laura B Dunn; Bradley E Aouizerat; Steven M Paul; Bruce A Cooper; John Neuhaus; Claudia West; Marylin Dodd; Christine Miaskowski
Journal:  Cancer Nurs       Date:  2014 Nov-Dec       Impact factor: 2.592

Review 5.  Quantifying psychological distress among cancer patients in interventions and scales: a systematic review.

Authors:  Mei-Ling Yeh; Yu-Chu Chung; Man-Ying F Hsu; Chin-Che Hsu
Journal:  Curr Pain Headache Rep       Date:  2014-03

Review 6.  Depression Induced by Total Mastectomy, Breast Conserving Surgery and Breast Reconstruction: A Systematic Review and Meta-analysis.

Authors:  Chengjiao Zhang; Guangfu Hu; Ewelina Biskup; Xiaochun Qiu; Hongwei Zhang; Haiyin Zhang
Journal:  World J Surg       Date:  2018-07       Impact factor: 3.352

7.  A randomized, controlled, double-blinded clinical trial of gabapentin 300 versus 900 mg versus placebo for anxiety symptoms in breast cancer survivors.

Authors:  Jill E Lavigne; Charles Heckler; Jennifer L Mathews; Oxana Palesh; Jeffrey J Kirshner; Raymond Lord; Andrew Jacobs; Eric Amos; Gary R Morrow; Karen Mustian
Journal:  Breast Cancer Res Treat       Date:  2012-10-02       Impact factor: 4.872

8.  Spirituality, Distress and Posttraumatic Growth in Breast Cancer Patients.

Authors:  Ana Cristina Paredes; M Graça Pereira
Journal:  J Relig Health       Date:  2018-10

9.  Children and Employment - Resource or Stressors after Breast Cancer?

Authors:  K Ebenhan; K Leuteritz; Y Barthel; M E Beutel; K Papsdorf; G Weissflog; E Brähler
Journal:  Geburtshilfe Frauenheilkd       Date:  2013-08       Impact factor: 2.915

10.  Exploring clinical determinants and anxiety symptom domains among Asian breast cancer patients.

Authors:  Yin Ting Cheung; Helen Hoi-Lun Lee; Alexandre Chan
Journal:  Support Care Cancer       Date:  2013-03-09       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.